Earning Preview: MP Materials Corp. this quarter’s revenue is expected to increase by 20.05%, and institutional views are bullish

Earnings Agent
04/30

Abstract

MP Materials Corp. will report first-quarter 2026 results on May 7, 2026 Post Market; this preview outlines consensus expectations for revenue, profitability and EPS, the key operating levers into the print, and how recent analyst calls frame the near-term setup.

Market Forecast

For the first quarter of 2026, forecasts point to total revenue of 76.46 million US dollars, up 20.05% year over year, with an estimated adjusted EPS of -0.003 US dollars per share, implying a 97.51% year-over-year improvement; the EBIT outlook implies a 26.71 million US dollars loss, a 24.13% year-over-year improvement. Forecasts for gross margin and net margin were not provided. Operationally, the mix remains centered on neodymium-praseodymium (NdPr) oxide and metal and increasingly on magnetic precursor products, with near-term profit sensitivity tied to product mix, realized pricing, and downstream ramp progress. The most promising segment is magnetic precursor products, which generated 66.86 million US dollars in the last reported breakdown; with company-level revenue expected to rise 20.05% year over year this quarter, this category is positioned to be a disproportionately important contributor.

Last Quarter Review

In the fourth quarter of 2025, MP Materials Corp. reported revenue of 52.69 million US dollars, a gross profit margin of 56.56%, GAAP net profit attributable to shareholders of 9.43 million US dollars, a net profit margin of 9.09%, and adjusted EPS of 0.09 US dollars per share, up 175% year over year. A notable financial highlight was an EPS outperformance versus the preceding consensus estimate around 0.00 US dollars per share, reflecting both cost discipline and favorable product mix relative to expectations; net profit growth also accelerated sequentially. By main lines in the last reported breakdown, NdPr oxide and metal delivered 115.13 million US dollars, magnetic precursor products 66.86 million US dollars, rare earth concentrate 41.99 million US dollars, and other rare earth products 3.25 million US dollars, while the quarter’s total revenue declined 13.61% year over year to 52.69 million US dollars.

Current Quarter Outlook

Main revenue engine and margin trajectory

The company’s core revenue engine in the near term remains sales of NdPr oxide and metal, supplemented by rare earth concentrates as needed to balance demand and production scheduling. With first-quarter 2026 revenue projected at 76.46 million US dollars, the most direct drivers into the print are product mix, realized pricing, and shipment timing. The prior quarter’s 56.56% gross margin illustrates how fixed-cost absorption and a richer mix can cushion profitability, but the current-quarter EBIT forecast of a 26.71 million US dollars loss suggests continued investment and pre-operating costs from downstream initiatives are still weighing on operating income. Given that EPS is forecast at approximately -0.003 US dollars per share, consensus appears to be underwriting a modest quarter of consolidation rather than a margin inflection. Investors will be scrutinizing any commentary on unit economics, including the evolution of conversion costs and how quickly higher-value downstream volumes can scale. Execution on these operating levers is likely to have an outsized impact on incremental margins relative to changes in headline volumes alone.

Most promising growth lever: magnetic precursor and magnetization ramp

Magnetic precursor products represent the largest growth potential within the current business mix, already contributing 66.86 million US dollars in the latest breakdown and positioned for further scaling as downstream capacity comes online. Management’s announced manufacturing campus in Northlake, Texas, with an expected investment of over 1.25 billion US dollars and a planned annual capacity of 10,000 metric tons of NdFeB magnets, is a multi-year growth platform; near term, progress milestones and early-stage shipments tied to precursor and magnetization capabilities are key to accelerating revenue quality and mix. The operating thesis is that each step downstream raises value capture per unit and reduces exposure to variability in upstream realized prices. This quarter’s consensus implies a 20.05% year-over-year revenue increase, and investors broadly expect the magnetic precursor category to outgrow aggregate company revenue over time as the downstream funnel expands. Evidence of customer readiness, qualification timelines, and production yields will be central to validating that trajectory. Commentary on order coverage and backlog specific to precursor and magnet components would further strengthen the case for upward revisions to medium-term revenue and margin expectations.

What will most influence the stock this quarter

The most important swing factors for the share price into and out of the print are the revenue/EPS delta versus consensus, clarity on downstream ramp timing and economics, and updates on capital spending and operating expense cadence. A top-line beat with better-than-expected loss containment would support the view that operating leverage is emerging even before full-scale magnet production, while any indication of delays or cost overruns could extend the EBIT loss profile. The market will also parse cash flow details for signs of working-capital normalization after the fourth quarter and for visibility on the pace of cash burn relative to capex plans. Additionally, the company announced in late February 2026 that it selected a Texas site for the magnet manufacturing campus; management’s commentary on permitting, construction, and commercial milestones will help frame when downstream revenue can inflect. Given the implied quarterly EBIT loss, the cadence of operating expenses tied to personnel, commissioning, and qualification will matter for how quickly operating margins can converge toward breakeven on a run-rate basis. Finally, investor sentiment is likely to react to any updates on multi-year supply agreements or price-floor mechanisms that increase revenue predictability and reduce earnings volatility.

Analyst Opinions

Among recent views from January 1, 2026 through April 30, 2026, the ratio of bullish to bearish opinions is decisively positive, with a 100% bullish skew based on the items captured in this window. One firm initiated coverage with an Outperform rating and a 90.00 US dollars price target on April 20, 2026, citing confidence in downstream execution and the multi-year revenue and margin uplift from magnet manufacturing. Another major bank adjusted its target to 65.00 US dollars while maintaining a Buy rating on March 2, 2026, emphasizing favorable positioning for scale-up and operating leverage as downstream volumes phase in. A large research house began coverage with a Buy rating on January 13, 2026, highlighting how risk-mitigation measures secured last year and the company’s downstream build-out improve the visibility of future cash generation. In late March 2026, another global bank maintained a Buy rating with a 76.00 US dollars target, reinforcing the constructive stance on execution milestones and earnings power recovery. The majority view coalesces around three points relevant for this quarter’s print. First, consensus expects downstream progress to steadily lift mix and reduce revenue variability, even if early-phase expenses keep EBIT in the red near term. Second, repeated Buy or Outperform stances and rising targets since the start of the year reflect confidence that each incremental commissioning step unlocks margin expansion, which could show up first in sequential improvements to unit economics and working-capital efficiency. Third, the strong clustering of positive ratings provides a supportive backdrop into May 7, 2026, with the potential for estimate revisions if management demonstrates faster-than-expected ramp, firmer order coverage, or more favorable cost trajectories. Overall, the dominant institutional stance is bullish, centered on execution against the downstream roadmap and the implied improvement in earnings quality as revenue shifts toward higher-value products.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10